Skip to content
411 PRESS
InfoRecall #D-0223-2026Drug / Pharmaceutical

Winder Laboratories Recalls Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL)

Winder Laboratories, LLC · Class III — Regulatory

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, Manufactured By: /winder Laboratories, LLC, Winder, GA 30680. NDC: 75826-131-01

Reason for Recall

Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.

FDA Classification

Class III — Regulatory

A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.

Distribution

U.S. Nationwide

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

The FDA has classified this as a Class III recall — the lowest severity level — for a pharmaceutical product recalled by Winder Laboratories, LLC on November 26, 2025. Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton. This recall covers 3,528 30 mL Bottles, distributed in U.S. Nationwide. Class III recalls typically involve products unlikely to cause health problems but that violate FDA manufacturing or labeling regulations.

Independent news on labor, safety, and accountability.